Pancreatic neuroendocrine tumours

European Journal of Surgical Oncology

Volumn 34, Issue 3, 2008, Pages 324-332

  O'Grady, H L ^a   Conlon, K C ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Gastrinoma; Insulinoma; Neuroendocrine; Pancreas

Indexed keywords

SOMATOSTATIN DERIVATIVE; STREPTOZOCIN;

CANCER HORMONE THERAPY; CANCER INCIDENCE; CHEMOEMBOLIZATION; GASTRINOMA; GLUCAGONOMA; HEPATIC ARTERY; HORMONE RELEASE; HUMAN; INSULINOMA; ISOTOPE LABELING; METASTASIS; MULTIMODALITY CANCER THERAPY; NEUROENDOCRINE TUMOR; PANCREAS ISLET CELL CARCINOMA; PANCREAS ISLET CELL TUMOR; PANCREAS RESECTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RARE DISEASE; REVIEW; SOMATOSTATINOMA; SURVIVAL TIME; SYMPTOMATOLOGY; SYNDROME; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; VIPOMA;

ADENOMA, ISLET CELL; ALGORITHMS; CARCINOMA, ISLET CELL; DIAGNOSTIC IMAGING; HUMANS; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 39749182242     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.07.209     Document Type: Review

References (74)

1. Moldow R.E., and Connolly R.R. Epidemiology of pancreatic cancer in Connecticut. Gastroenterology 55 (1968) 677-686
2. Danforth D.N., Gorden P., and Brennan M.F. Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. Surgery 96 (1984) 1027-1037
3. Heitz P.U., Kasper M., Polak J.M., and Kloppel G. Pancreatic endocrine tumours: immunocytochemical analysis of 125 tumors. Hum Pathol 13 (1982) 263-271
4. Nicholls A.G. Simple adenoma of the pancreas arising from an island of langerhans. J Med Res 8 (1902) 385
5. Larsson L. Endocrine pancreatic tumours. Hum Pathol 9 (1978) 401
6. Chen H., Hardacre J.M., Uzar A., Cameron J.L., and Chot M.A. Isolated liver metastases from neuroendocrine tumors: does surgical resection prolong survival?. J Am Coll Surg 187 (1998) 88
7. Kloppel G., and Heitz P.U. Pancreatic endocrine tumours. Pathol Res Pract 183 (1988) 155
8. Capella C., Heitz P.U., Hofler H., Solcia E., and Kloppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Archiv 425 (1995) 547
9. Thompson N.W., and Eckhauser F.E. Malignant islet cell tumors of the pancreas. World J Surg 8 (1984) 940-951
10. Thompson G.B., Van Heerden J.A., Grant C.S., Carney A., and Ilstrup D.M. Islet cell carcinomas of the pancreas: a twenty year experience. Surgery 104 (1988) 1011-1017
11. Grant C.S. Surgical management of malignant islet cell tumours. World J Surg 17 (1993) 498-503
12. Weber H.C., Venzon D.J., and Lin J.T. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 108 (1995) 1673-1649
13. Yu F., Vernon D.J., and Serrano J. Prospective study of the clinical course, prognostic factors and survival in patients with Zollinger-Ellison syndrome. J Clin Oncol 17 (1999) 615-630
14. Hochwald S.N., Lee S., Conlon K.C., et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 20 (2002) 2633-2642
15. Phan G.Q., Yeo C.J., and Ruben R.H. Surgical experience with pancreatic and per pancreatic neuroendocrine tumours: review of 125 patients. J Gastrointest Surg 2 (1998) 473-482
16. Roy P., Venzon D.J., and Shojamanesh H. Zollinger-Ellison syndrome: clinical presentation in 261 patients. Medicine 79 (2000) 379-411
17. Gorman B., Charboneau J.W., James E.M., Reading C.C., Galiber A.K., and Grant C.S. Benign pancreatic insulinoma: preoperative and intraoperative sonographic localization. AJR Am J Roentgenol 181 (2003) 987-992
18. Galiber A.K., Reading C.C., Charboneau J.W., Sheedy P.F., James E.M., and Gorman B. Localization of pancreatic insulinoma: comparison of pre- and intraoperative US with CT and angiography. Radiology 166 (1988) 405-408
19. Vilmann P., Hancke S., Henriksen F.W., and Jacobsen G.K. Endoscopically-guided fine needle aspiration biopsy of malignant lesions in the upper gastrointestinal tract. Endoscopy 25 (1993) 523-527
20. Anderson M.A., Carpenter S., and Thompson N.W. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumours of the pancreas. Am J Gastroenterol 95 (2000) 2271-2277
21. De Angelis C., Carucci P., Repici A., and Rizzetto M. Endosonography in decision making and management of gastrointestinal endocrine tumors. Eur J Ultrasound 10 (1999) 139-150
22. McLean A.M., and Fairclough P.D. Endoscopic ultrasound in the localization of pancreatic islet cell tumours. Best Pract Res Clin Endocrinol Metab 19 (2005) 177-193
23. Zimmer T., Stolzel U., and Bader M. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut 39 (1996) 562-568
24. Cadiot G., Lebtahi R., and Sarda L. Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somostatin receptor scintigraphy. Gastroenterology 111 (1996) 845-854
25. Mertz H., and Gautam S. The learning curve for EUS-guided FNA of pancreatic cancer. Gastrointest Endosc 59 (2004) 33-37
26. Gouya H., Vignaux O., Augui J., Dousset B., Palazzo L., and Louvel A. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol 181 (2003) 987-992
27. Brizi M.G., Natale L., Manfredi R., Sallustico G., Vecchioli A., and Marano P. High resolution spiral computed tomography of the pancreas. Rays 26 (2001) 111-115
28. Van Hoe L., Gryspeerdt S., Marchal G., Baert A.L., and Merters L. Helical CT for the preoperative localization of islet cell tumours the pancreas: value of arterial and parenchymal phase images. Am J Roentgenol 165 (1995) 1437
29. Fidler J.L., and Johnson C.D. Imaging of neuroendocrine tumors of the pancreas. Intl J Gastrointestinal Cancer 30 (2001) 73
30. Smelka R.C., Cumming M.J., Shoenut J.P., Magro C.M., Yaffe C.S., and Kroeker M.A. Islet cell tumours: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. Radiology 186 (1993) 799-802
31. Muller M.F., Meyenberger C., Bertschinger P., Schaer R., and Marincek B. Pancreatic tumors: evaluation with endoscopic US, CT and MR imaging. Radiology 190 (1994) 745-751
32. Boukhman M.P., Karam J.M., Shaver J., Siperstein A.E., DeLorimer A.A., and Clark O.H. Localization of insulinomas. Arch Surg 134 (1999) 818-823
33. Lo C.Y., Chan F.L., Tam S.C., Cheng P.W., Fan S.T., and Lam K.S. Value of intraarterial calcium stimulated venous sampling for regionalization of pancreatic insulinomas. Surgery 128 (2000) 903-909
34. Doppman J.L., Miller D.L., Chang R., Shawker T.H., Gorden P., and Norton J.A. Insulinomas: localization with selective intraarterial injection of calcium. Radiology 178 (1991) 237-241
35. Aoki T., Sakon M., Ohzato H., Kishimoto S., Oshima S., and Yamada T. Evaluation of preoperative and intraoperative arterial stimulation and venous sampling for diagnosis and surgical resection of insulinoma. Surgery 126 (1999) 968-973
36. Doppman J.L., Chang R., Fraker D.L., Norton J.A., Alexander H.R., and Miller D.L. Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med 123 (1995) 269-273
37. van der Lely A.J., de Herder W.W., Krenning E.P., and Kwekkeboom D.J. Octreoscan radioceptor imaging. Endocrine 20 (2003) 307-311
38. Oberg K., Kvols L., Caplin M., et al. Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastropancreatic system. Ann Oncol 15 (2004) 966-973
39. Knenning E.P., Kwekkeboom D.J., Oei H.Y., et al. Somatostatin receptor scintigraphy in gastropancreatic tumors: an overview of European results. Ann N Y Acad Sci 733 (1994) 416
40. Scherubl H., Boder M., Fett U., et al. Somatostatin receptor imaging of neuroendocrine gastropancreatic tumors (comment). Gastroenterology 105 (1993) 1705
41. Grover A.C., Skarulis M., Alexander R., et al. A prospective evaluation of laparoscopic exploration with intraoperative ultrasound as a technique for localizing sporadic insulinomas. Surgery 138 (2005) 1003-1008
42. Glaser K.S., Tschmelitsch J., Klinger A., Klinger P., and Bodner P. "Is there a role for laparoscopic ultrasonography (LUS)?". Surg Laparosc Endosc 5 (1995) 370-375
43. Rosiere A. Neuroendocrine tumors of the pancreas- benefits of new technologies. Surg Endosc 19 (2005) 1004-1005
44. Marks V., and Teale J.D. Hypoglycemia: factitous and felonious. Endocrinol Met Clin North Am 28 (1999) 579-601
45. Scarlett J.A., Mako M.E., Rubenstein A.H., Blix P.M., Goldman J., and Horwitz D.L. Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin binding antibodies. N Engl J Med 297 (1977) 1029-1032
46. Grant C.S. Insulinoma. Surg Oncol Clin North Am 7 (1998) 819-844
47. Buttger T.C., and Junginger T. Is preoperative radiographic localization of islet cell tumours in patients with insulinoma necessary?. World J Surg 17 (1993) 427
48. Ramage J.K., Davies A.H., Ardill J., Bax N., Caplin M., and Grossman A. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 54 Suppl 4 (2005) 1-16 iv
49. Mabrut J.Y., Fernandez-Cruz L., Azagra J.S., et al. Laparoscopic pancreatic resection: results of a multicentre European study of 127 patients. Surgery 137 (2005) 597-605
50. Danforth D.N., Gorden P., and Brennan M.F. Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. Surgery 104 (1988) 1027-1037
51. Thompson G.B., van Heerden J.A., Grant C.S., Carney J.A., and Iistrup D.M. Islet cell carcinomas of the pancreas: a twenty year experience. Surgery 96 (1988) 1011-1017
52. Jensen R.T. Pancreatic endocrine tumors: recent advances. Ann Oncol 10 Suppl (1999) 6
53. Roy P.K., Venzon D.J., Shojamanesh H., et al. Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine 79 (2000) 379
54. Howard T.J., Stabile B.E., Zinner M.J., Chang S., Bhagavan B.S., and Passaro E. Anatomic distribution of pancreatic endocrine tumors. Am J Surg 159 (1990) 258
55. Fishbeyn V.A., Norton J.A., Benya R.V., et al. Assessment and prediction of long-term cure in patients with Zollinger-Ellison syndrome: the best approach. (comment). Ann Intl Med 119 (1993) 199
56. Norton J.A., Fraker D.L., Alexander H.R., et al. Surgery increases survival in Patients with Gastrinoma. Ann Surg 244 (2006) 410-419
57. Norton J.A., Doppman J.L., and Jensen R.T. Curative resection in Zollinger-Ellison syndrome: results of a 10-year prospective study. Ann Surg 215 (1992) 8-18
58. Norton J.A. Gastrinoma: advances in localization and treatment. Surg Oncol Clin North Am 7 (1998) 845-8610
59. Norton J.A., Fraker D.L., Alexander H.R., et al. Surgery to cure the Zollinger-Ellison Syndrome. N Engl J Med 341 (1999) 635-644
60. Becker S.W., Khan D., and Rothman S. Cutaneous manifestations of internal malignant tumours. Arch Dermatol Syphilol 45 (1942) 1069-1080
61. Werners R.A., Fatourechi V., Wynne A.G., Kvols L.K., and Lloyd R.V. The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Medicine 75 (1996) 53-63
62. Stacpoole P.W. The glucagonoma syndrome: clinical features, diagnosis and treatment. Endocr Rev 2 (1981) 347
63. Nightingale K.J., Davies M.G., and Kingsworth A.N. Glucagonoma syndrome: survival 24 years following diagnosis. Digest Surg 16 (1999) 68-71
64. Altimari A.F., Bhoopalam N., O'Dorsio T., Lange C.L., Sandberg L., and Prinz R.A. Use of a somatostatin analogue (SMS 201-995) in the glucagonoma syndrome. Surgery 100 (1986) 989-996
65. Priest W.M., and Alexander M.K. Islet-cell tumour of the pancreas with peptic ulceration, diarrhea, and hypokalaemia. Lancet 2 (1957) 1145
66. Verner J.V., and Morrison A.B. Islet-cell tumour and a syndrome of refractory watery diarrhea and hypokalaemia. Am J Med 25 (1958) 374
67. Maton P.N., O'Drisio T.M., Howe B.A., et al. Effect of long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera. N Engl J Med 17 (1985) 312
68. Kazanijian K.K., Reber H.A., and Hines O.J. Resection of pancreatic neuroendocrine tumours. Results of 70 cases. Arch Surg 141 (2006) 765-770
69. Norton J.A. Somatostatinoma and rare pancreatic endocrine tumours. In: Clarke O.H., and Duh Q.Y. (Eds). Textbook of endocrine surgery (1997), WB Saunders, Philadelphia 626
70. Mozell E., Stenzel P., Woltering E.A., Rosch J., and O'Doriso T.M. Functional endocrine tumors of the pancreas: clinical presentation, diagnosis, and treatment. Curr Prob Surg 27 (1990) 303-386
71. Perry R.R., and Vinik A. Clinical review 72. Diagnosis and management of functioning islet cell tumours. J Clin Endocrinol Metab 80 (1995) 2273-2278
72. Gribril F., Doppman J.L., and Jensen R.T. Recent advances in the treatment of metastatic pancreatic neuroendocrine tumours. Semin Gastrointestin Dis 6 (1995) 114-121
73. Arnold R., Trautmann M.E., and Creutzfedt W. Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut 38 (1996) 430-480
74. Gupta S., Johnson M.M., Murthy R., et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumours. Variables affecting response rates and survival. Cancer 104 (2005) 1590-1602